130 related articles for article (PubMed ID: 6801370)
1. Circulating immune complexes in membranoproliferative glomerulonephritis.
Davis CA; Marder H; West CD
Kidney Int; 1981 Dec; 20(6):728-32. PubMed ID: 6801370
[TBL] [Abstract][Full Text] [Related]
2. Serum immune complexes in membranoproliferative and other glomerulonephritides.
Ooi YM; Vallota EH; West CD
Kidney Int; 1977 Apr; 11(4):275-83. PubMed ID: 853604
[TBL] [Abstract][Full Text] [Related]
3. Determination of circulating immune complexes, C3 and C4 complement components and anti-DNA antibody in different classes of lupus nephritis.
Klein MH; Thorner PS; Yoon SJ; Poucell S; Baumal R
Int J Pediatr Nephrol; 1984 Jun; 5(2):75-82. PubMed ID: 6333404
[TBL] [Abstract][Full Text] [Related]
4. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.
Perrin LH; Lambert PH; Miescher PA
J Clin Invest; 1975 Jul; 56(1):165-76. PubMed ID: 1141431
[TBL] [Abstract][Full Text] [Related]
5. Studies on circulating immune complexes. II: Circulating immune complexes in primary IgA nephropathy and membranoproliferative glomerulonephritis.
Miura Y
Nihon Jinzo Gakkai Shi; 1989 Feb; 31(2):193-200. PubMed ID: 2739118
[TBL] [Abstract][Full Text] [Related]
6. Complement activation in renal disease.
West CD
Uremia Invest; 1984-1985; 8(3-4):225-35. PubMed ID: 6545495
[TBL] [Abstract][Full Text] [Related]
7. [Immune complexes and C3 and C4 of the complement in urine of patients with glomerulonephritis].
Kacprzyk F; Chrzanowski W
Pol Arch Med Wewn; 1996 Sep; 96(3):215-23. PubMed ID: 9122012
[TBL] [Abstract][Full Text] [Related]
8. The effect of age on the character of immune complex disease: a comparison of the incidence and relative size of materials reactive with Clq in sera of patients with glomerulonephritis and cancer.
Rossen RD; Reisberg MA; Singer D; Suki WN; Duffy J; Hersh EM; Schloeder FX; Hill LL; Eknoyan G
Medicine (Baltimore); 1979 Jan; 58(1):65-79. PubMed ID: 154003
[TBL] [Abstract][Full Text] [Related]
9. Circulating immune complexes and complement breakdown product C3d in glomerulonephritis and kidney transplantation.
Sølling J
Acta Pathol Microbiol Immunol Scand C; 1984 Aug; 92(4):213-20. PubMed ID: 6391086
[TBL] [Abstract][Full Text] [Related]
10. [Studies of complement, nephritic factor, and circulating immune complexes in chronic mesangiocapillary glomerulonephritis types I and II (author's transl)].
Mirapeix E; Yagüe J; Vives J; Revert L
Med Clin (Barc); 1981 Jun; 77(1):21-6. PubMed ID: 7253758
[TBL] [Abstract][Full Text] [Related]
11. Studies on circulating immune complexes. I: Circulating immune complexes in various types of glomerulonephritis and collagen disease: a comparative study employing conglutinin solid phase radioimmunoassay and raji cell radioimmunoassay.
Miura Y
Nihon Jinzo Gakkai Shi; 1989 Feb; 31(2):185-92. PubMed ID: 2739117
[TBL] [Abstract][Full Text] [Related]
12. Serum immunoglobulin sedimentation patterns and circulating immune complexes in IgA glomerulonephritis and Schönlein-Henoch nephritis.
Danielsen H; Eriksen EF; Johansen A; Sølling J
Acta Med Scand; 1984; 215(5):435-41. PubMed ID: 6377828
[TBL] [Abstract][Full Text] [Related]
13. Correlation and predictive accuracy of circulating immune complexes with disease activity in patients with systemic lupus erythematosus.
Abrass CK; Nies KM; Louie JS; Border WA; Glassock RJ
Arthritis Rheum; 1980 Mar; 23(3):273-82. PubMed ID: 6987992
[TBL] [Abstract][Full Text] [Related]
14. Circulating immune complexes in systemic lupus erythematosus: a reappraisal of the solid phase C1q radioimmunoassay.
Woodroffe AJ; Nozza JM; Muller KD; McIntosh SL; Hale GM; Clarkson AR
J Clin Lab Immunol; 1988 May; 26(1):5-7. PubMed ID: 3263507
[TBL] [Abstract][Full Text] [Related]
15. [Behavior of the nephritic factor and of circulating immune complexes in cryoglobulinemic glomerulonephritis].
Pertosa G; Vox E; Pastore A; Schena FP
Minerva Nefrol; 1979; 26(3):251-5. PubMed ID: 262262
[No Abstract] [Full Text] [Related]
16. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.
Servais A; Frémeaux-Bacchi V; Lequintrec M; Salomon R; Blouin J; Knebelmann B; Grünfeld JP; Lesavre P; Noël LH; Fakhouri F
J Med Genet; 2007 Mar; 44(3):193-9. PubMed ID: 17018561
[TBL] [Abstract][Full Text] [Related]
17. [Partial lipodystrophy, hypocomplementemia and glomerulonephritis].
Habib R; Lévy M; Gubler MC; Broyer M; Habib M
Arch Fr Pediatr; 1977; 34(7 Suppl):CXCVII-CCXII. PubMed ID: 931525
[TBL] [Abstract][Full Text] [Related]
18. Terminal complement complex in plasma from patients with systemic lupus erythematosus and other glomerular diseases.
Horigome I; Seino J; Sudo K; Kinoshita Y; Saito T; Yoshinaga K
Clin Exp Immunol; 1987 Nov; 70(2):417-24. PubMed ID: 3427827
[TBL] [Abstract][Full Text] [Related]
19. Differences between membranoproliferative glomerulonephritis types I and III in clinical presentation, glomerular morphology, and complement perturbation.
Jackson EC; McAdams AJ; Strife CF; Forristal J; Welch TR; West CD
Am J Kidney Dis; 1987 Feb; 9(2):115-20. PubMed ID: 3826060
[TBL] [Abstract][Full Text] [Related]
20. Circulating immune complexes in glomerulonephritis: a longitudinal study.
Sølling J
Clin Nephrol; 1983 Oct; 20(4):177-89. PubMed ID: 6139194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
